Randomized phase III trial of cisplatin/irinotecan versus cisplatin/etoposide in patients with extensive-stage small-cell lung cancer.
Lara
Primo N
PN
University of California, Davis Cancer Center, Sacramento, CA 95817-2229, USA. primo.lara@ucdmc.ucdavis.edu
Gandara
David R
DR
Natale
Ronald B
RB
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives; D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D000077146:Irinotecan; D008175:Lung Neoplasms / Q000188:drug therapy*; D015996:Survival Rate
D005047:Etoposide; D000077146:Irinotecan; D002945:Cisplatin; D002166:Camptothecin